Corpus Intelligence IC Memo — LITTLETON REGIONAL HEALTHCARE 2026-04-26 07:43 UTC
IC Memo — LITTLETON REGIONAL HEALTHCARE
Investment Committee Memorandum | NH | 25 beds | Grade C | EBITDA uplift $7.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LITTLETON REGIONAL HEALTHCARE

CCN 301302 | GRAFTON, NH | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

LITTLETON REGIONAL HEALTHCARE is a 25-bed suburban community hospital in GRAFTON, NH with $98.2M in net patient revenue and a -10.4% operating margin. The hospital serves a payer mix of 36.2% Medicare, 0.0% Medicaid, and 63.7% commercial.

Thesis: Turnaround. Our ML models identify $7.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -10.4% to -3.0% (+736bps).

Net Revenue HCRIS$98.2M
Current EBITDA COMPUTED$-10.2M
Operating Margin COMPUTED-10.4%
Occupancy HCRIS55.2%
Revenue / Bed COMPUTED$3.9M
Net-to-Gross HCRIS43.5%
Distress Probability ML43.5%

2. Market Context & Competitive Position

30
NH Hospitals
-2.7%
State Median Margin
13
Comparable Hospitals

NH has 30 Medicare-certified hospitals with a median operating margin of -2.7%. The target's margin of -10.4% places it below the state median. Among 13 size-comparable peers (12-50 beds), the median margin is -1.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 13 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LITTLETON REGIONAL HEALTHCARE (Target)NH25$98.2M-10.4%
MEMORIAL HOSPITALNH25$97.7M1.3%
ALICE PECK DAY MEMORIAL HOSPITNH24$94.3M-1.5%
NEW LONDON HOSPITALNH25$87.9M0.5%
HUGGINS HOSPITALNH25$86.3M-8.3%
MONADNOCK COMMUNITY HOSPITALNH25$85.8M-9.4%
ANDROSCOGGIN VALLEY HOSPITALNH25$72.7M-2.3%
SPEARE MEMORIAL HOSPITALNH25$72.5M-6.1%
WEEKS MEDICAL CENTERNH25$67.4M-8.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.1M+210bp18mo
Cost to Collect4.5%2.5%$2.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.2M+122bp9mo
Clean Claim Rate88.0%96.0%$63K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.1M
Cost to Collect
$2.0M
Denial Rate Reduction
$1.9M
A/R Days Reduction
$1.2M
Clean Claim Rate
$63K
Total EBITDA Uplift$7.2M
Current EBITDA$-10.2M
+ RCM Uplift+$7.2M
Pro Forma EBITDA$-3.0M
Current Margin-10.4%
Pro Forma Margin-3.0%
WC Released (1x)$3.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-15.7M$5.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-15.7M$454K0.00x-100.0%
Bull Case9.0x11.0x$-14.1M$19.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-14.1M$16.8M0.00x-100.0%
Bear Case11.0x10.0x$-17.2M$-26.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-17.2M$-34.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 13 hospitals with 12-50 beds
  • Same-state prioritization (n=14)
  • Comp margins: P25=-8.3% / P50=-1.5% / P75=0.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.